Tech Transfer Roundup: Trio Of Deals Bolster Spherix’s Cancer Strategy

 
• By Joseph Haas

The New York biotech announces option deals with two universities, asset license from CBM BioPharma. Bayer inks research collaborations with Japan’s RiKen and with a pair of Boston research hospitals.

Tech Transfer regular column feature image

More from Deals

More from Business